-
公开(公告)号:US11931145B2
公开(公告)日:2024-03-19
申请号:US17542655
申请日:2021-12-06
Applicant: Medtronic MiniMed, Inc.
Inventor: Rajiv Shah , Jesper Svenning Kristensen , Katherine T. Wolfe , Soren Aasmul , Anubhuti Bansal
IPC: A61B5/145 , A61B5/00 , A61B5/1455 , A61B5/1459 , A61B5/1473 , A61M5/172 , G01N21/64 , G01N21/77 , G01N33/66
CPC classification number: A61B5/14532 , A61B5/0002 , A61B5/0004 , A61B5/14556 , A61B5/1459 , A61B5/1473 , A61B5/4839 , A61B5/6848 , A61B5/6849 , A61B5/742 , A61M5/1723 , G01N21/6408 , G01N21/6428 , G01N21/7703 , G01N33/66 , A61M2230/201 , G01N2021/6441 , G01N2021/6484 , G01N2021/772 , G01N2021/7733 , G01N2021/775 , G01N2021/7759 , G01N2021/7786 , G01N2333/4724
Abstract: A continuous glucose monitoring system may include a hand-held monitor, a transmitter, an insulin pump, and an orthogonally redundant glucose sensor, which may comprise an optical glucose sensor and a non-optical glucose sensor. The former may be a fiber optical sensor, including a competitive glucose binding affinity assay with a glucose analog and a fluorophore-labeled glucose receptor, which is interrogated by an optical interrogating system, e.g., a stacked planar integrated optical system. The non-optical sensor may be an electrochemical sensor having a plurality of electrodes distributed along the length thereof. Proximal portions of the optical and electrochemical sensors may be housed inside the transmitter and operationally coupled with instrumentation for, e.g., receiving signals from the sensors, converting to respective glucose values, and communicating the glucose values. The sensors' distal portions may be inserted into a user's body via a single delivery needle and may be co-located inside the user's body.
-
公开(公告)号:US10194845B2
公开(公告)日:2019-02-05
申请号:US15474535
申请日:2017-03-30
Applicant: MEDTRONIC MINIMED, INC.
Inventor: Rajiv Shah , Jesper Svenning Kristensen , Katherine T. Wolfe , Soren Aasmul , Anubhuti Bansal
IPC: A61B5/00 , A61B5/145 , A61B5/1455 , A61B5/1459 , A61B5/1473 , G01N21/64 , G01N21/77 , G01N33/66 , A61M5/172
Abstract: A continuous glucose monitoring system may include a hand-held monitor, a transmitter, an insulin pump, and an orthogonally redundant glucose sensor, which may comprise an optical glucose sensor and a non-optical glucose sensor. The former may be a fiber optical sensor, including a competitive glucose binding affinity assay with a glucose analog and a fluorophore-labeled glucose receptor, which is interrogated by an optical interrogating system, e.g., a stacked planar integrated optical system. The non-optical sensor may be an electrochemical sensor having a plurality of electrodes distributed along the length thereof. Proximal portions of the optical and electrochemical sensors may be housed inside the transmitter and operationally coupled with instrumentation for, e.g., receiving signals from the sensors, converting to respective glucose values, and communicating the glucose values. The sensors' distal portions may be inserted into a user's body via a single delivery needle and may be co-located inside the user's body.
-
公开(公告)号:US20220087578A1
公开(公告)日:2022-03-24
申请号:US17542655
申请日:2021-12-06
Applicant: Medtronic MiniMed, Inc.
Inventor: Rajiv Shah , Jesper Svenning Kristensen , Katherine T. Wolfe , Soren Aasmul , Anubhuti Bansal
IPC: A61B5/145 , A61B5/00 , A61B5/1455 , A61B5/1459 , A61B5/1473 , G01N21/64 , G01N21/77 , G01N33/66 , A61M5/172
Abstract: A continuous glucose monitoring system may include a hand-held monitor, a transmitter, an insulin pump, and an orthogonally redundant glucose sensor, which may comprise an optical glucose sensor and a non-optical glucose sensor. The former may be a fiber optical sensor, including a competitive glucose binding affinity assay with a glucose analog and a fluorophore-labeled glucose receptor, which is interrogated by an optical interrogating system, e.g., a stacked planar integrated optical system. The non-optical sensor may be an electrochemical sensor having a plurality of electrodes distributed along the length thereof. Proximal portions of the optical and electrochemical sensors may be housed inside the transmitter and operationally coupled with instrumentation for, e.g., receiving signals from the sensors, converting to respective glucose values, and communicating the glucose values. The sensors' distal portions may be inserted into a user's body via a single delivery needle and may be co-located inside the user's body.
-
公开(公告)号:US20240252068A1
公开(公告)日:2024-08-01
申请号:US18609419
申请日:2024-03-19
Applicant: Medtronic MiniMed, Inc.
Inventor: Rajiv V. Shah , Jesper Svenning Kristensen , Katherine T. Wolfe , Soren Aasmul , Anubhuti Bansal
IPC: A61B5/145 , A61B5/00 , A61B5/1455 , A61B5/1459 , A61B5/1473 , A61M5/172 , G01N21/64 , G01N21/77 , G01N33/66
CPC classification number: A61B5/14532 , A61B5/0002 , A61B5/0004 , A61B5/14556 , A61B5/1459 , A61B5/1473 , A61B5/4839 , A61B5/6848 , A61B5/6849 , A61B5/742 , A61M5/1723 , G01N21/6408 , G01N21/6428 , G01N21/7703 , G01N33/66 , A61M2230/201 , G01N2021/6441 , G01N2021/6484 , G01N2021/772 , G01N2021/7733 , G01N2021/775 , G01N2021/7759 , G01N2021/7786 , G01N2333/4724
Abstract: A continuous glucose monitoring system may include a hand-held monitor, a transmitter, an insulin pump, and an orthogonally redundant glucose sensor, which may comprise an optical glucose sensor and a non-optical glucose sensor. The former may be a fiber optical sensor, including a competitive glucose binding affinity assay with a glucose analog and a fluorophore-labeled glucose receptor, which is interrogated by an optical interrogating system, e.g., a stacked planar integrated optical system. The non-optical sensor may be an electrochemical sensor having a plurality of electrodes distributed along the length thereof. Proximal portions of the optical and electrochemical sensors may be housed inside the transmitter and operationally coupled with instrumentation for, e.g., receiving signals from the sensors, converting to respective glucose values, and communicating the glucose values. The sensors' distal portions may be inserted into a user's body via a single delivery needle and may be co-located inside the user's body.
-
公开(公告)号:US11229384B2
公开(公告)日:2022-01-25
申请号:US16203951
申请日:2018-11-29
Applicant: MEDTRONIC MINIMED, INC.
Inventor: Rajiv Shah , Jesper Svenning Kristensen , Katherine T. Wolfe , Soren Aasmul , Anubhuti Bansal
IPC: A61B5/145 , A61B5/00 , A61B5/1455 , A61B5/1459 , A61B5/1473 , G01N21/64 , G01N21/77 , G01N33/66 , A61M5/172
Abstract: A continuous glucose monitoring system may include a hand-held monitor, a transmitter, an insulin pump, and an orthogonally redundant glucose sensor, which may comprise an optical glucose sensor and a non-optical glucose sensor. The former may be a fiber optical sensor, including a competitive glucose binding affinity assay with a glucose analog and a fluorophore-labeled glucose receptor, which is interrogated by an optical interrogating system, e.g., a stacked planar integrated optical system. The non-optical sensor may be an electrochemical sensor having a plurality of electrodes distributed along the length thereof. Proximal portions of the optical and electrochemical sensors may be housed inside the transmitter and operationally coupled with instrumentation for, e.g., receiving signals from the sensors, converting to respective glucose values, and communicating the glucose values. The sensors' distal portions may be inserted into a user's body via a single delivery needle and may be co-located inside the user's body.
-
-
-
-